These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 3538570)
1. A safer approach to the clinical use of cyclosporine: the predose calculation. Lokiec F; Fischer A; Gluckman E Transplant Proc; 1986 Dec; 18(6 Suppl 5):194-9. PubMed ID: 3538570 [No Abstract] [Full Text] [Related]
2. Small intestinal transplantation and cyclosporine predose calculation. Lokiec F; Vernillet L; Le Bigot JF; Ricour C; Goulet O Transplant Proc; 1988 Apr; 20(2 Suppl 2):491-3. PubMed ID: 3363651 [No Abstract] [Full Text] [Related]
3. Prevention of graft versus host disease following allogeneic bone marrow transplantation. Powles RL; Goss GD; Millar J; Maitland J; Borthwick-Clark C; Al-Jundi A Tokai J Exp Clin Med; 1985 Jun; 10(2-3):133-8. PubMed ID: 3914738 [No Abstract] [Full Text] [Related]
4. The pharmacokinetics of cyclosporine A in uremic patients. Lindberg A; Odlind B; Tufveson G; Lindström B; Gabrielsson J Transplant Proc; 1986 Dec; 18(6 Suppl 5):144-52. PubMed ID: 3787709 [No Abstract] [Full Text] [Related]
5. Experiences with a blood level-adjusted cyclosporine regimen in kidney and liver allograft recipients. Wonigeit K; Hoyer PF; Schumann G; Ringe B; Frei A; Picklmayr R Transplant Proc; 1986 Dec; 18(6 Suppl 5):181-7. PubMed ID: 3538568 [No Abstract] [Full Text] [Related]
7. Therapeutic monitoring of cyclosporine following pediatric bone marrow transplantation: problems with sampling from silicone central venous lines. Leson CL; Bryson SM; Giesbrecht EE; Saunders EF DICP; 1989 Apr; 23(4):300-3. PubMed ID: 2658375 [TBL] [Abstract][Full Text] [Related]
8. Clinical pharmacology of cyclosporine in patients undergoing bone marrow transplantation. Yee GC; Lennon TP; Gmur DG; Carlin J; Schaffer RL; Kennedy MS; Deeg HJ Transplant Proc; 1986 Dec; 18(6 Suppl 5):153-9. PubMed ID: 3538566 [No Abstract] [Full Text] [Related]
9. Clinical trial depleting T lymphocytes from donor marrow for matched and mismatched allogeneic bone marrow transplants. Trigg ME; Billing R; Sondel PM; Exten R; Hong R; Bozdech MJ; Horowitz SD; Finlay JL; Moen R; Longo W Cancer Treat Rep; 1985 Apr; 69(4):377-86. PubMed ID: 3888387 [TBL] [Abstract][Full Text] [Related]
10. An application of population pharmacokinetics to the clinical use of cyclosporine in bone marrow transplant patients. Mentré F; Mallet A; Steimer JL; Lokiec F Transplant Proc; 1988 Apr; 20(2 Suppl 2):466-70. PubMed ID: 3284091 [No Abstract] [Full Text] [Related]
11. Growth in children after bone marrow transplantation for thalassemia. Gaziev J; Galimberti M; Giardini C; Baronciani D; Lucarelli G Bone Marrow Transplant; 1993; 12 Suppl 1():100-1. PubMed ID: 8374543 [No Abstract] [Full Text] [Related]
12. Comparison of cyclosporine A dosage and metabolism in liver and heart transplant recipients. Hamilton G; Mühlbacher F; Roth E; Wolf I; Piza F; Havel M; Laczkovics A; Schindler J; Wolosczuk W Transplant Proc; 1987 Feb; 19(1 Pt 2):1706-8. PubMed ID: 3547878 [No Abstract] [Full Text] [Related]
13. Risk factors for acute graft-versus-host disease in 325 consecutive bone marrow recipients. Hägglund H; Boström L; Ringdén O; Nilsson B; Remberger M Transplant Proc; 1994 Jun; 26(3):1821-2. PubMed ID: 8030154 [No Abstract] [Full Text] [Related]
14. Total lymphoid irradiation. Sutherland DE; Ferguson RM; Simmons RL; Kim TH; Slavin S; Najarian JS Urol Clin North Am; 1983 May; 10(2):277-88. PubMed ID: 6344387 [TBL] [Abstract][Full Text] [Related]
15. Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis. Carlens S; Ringdén O; Remberger M; Lönnqvist B; Hägglund H; Klaesson S; Mattsson J; Svahn BM; Winiarski J; Ljungman P; Aschan J Bone Marrow Transplant; 1998 Oct; 22(8):755-61. PubMed ID: 9827972 [TBL] [Abstract][Full Text] [Related]
16. Application of Bayesian forecasting to predict appropriate cyclosporine dosing regimens for renal allograft recipients. Kahan BD; Kramer WG; Williams C; Wideman CA Transplant Proc; 1986 Dec; 18(6 Suppl 5):200-3. PubMed ID: 3538571 [No Abstract] [Full Text] [Related]
17. Cyclosporine does not prevent in vivo expression of T cell activation antigens following allogeneic bone marrow transplantation. Forman SJ; Gallagher MT; Zaia JA; Wright C; Blume KG Transplantation; 1984 Feb; 37(2):219-20. PubMed ID: 6420961 [No Abstract] [Full Text] [Related]
18. [Therapy of thalassemia major with transplant of the bone marrow. Our experience with the busulfan, cyclophosphamide, cyclosporin, and acyclovir protocol]. Torlontano G; Iacone A; Di Bartolomeo P; Di Girolamo G; Natale D; Bonanni G Haematologica; 1985; 70(3):270-1. PubMed ID: 3932162 [No Abstract] [Full Text] [Related]